CARDIOVASCULAR EFFECTS OF AN ARGINASE II SELECTIVE INHIBITOR
For the first time in vitro experiments there were studied the inhibitory activity and safety of potential molecules arginase II selective inhibitors from the group of norleucine derivatives. Also first the substance under the code ZB49-0010C from the group of norleucine derivatives showed the great...
Saved in:
Main Authors: | Vladimir Yakushev (Author), Mikhail Pokrovskii (Author) |
---|---|
Format: | Book |
Published: |
Belgorod National Research University,
2016-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
STUDYING DOSE-DEPENDENT ENDOTHELIO- AND CARDIOPROTECTIVE ACTIVITY OF SELECTIVE ARGINASE II INHIBITOR IN HYPERHOMOCYSTEINE-INDUCED ENDOTHELIAL DYSFUNCTION
by: Vladimir Yakushev, et al.
Published: (2016) -
Study of the effect of selective inhibitor of Arginase II KUD 975 and of low doses of Acetylsalicylic acid on the functional parameters of the cardiovascular system In experimental preeclampsia
by: Olga V. Severinova, et al.
Published: (2019) -
Correction of morphofunctional disorders of the cardiovascular system with asialized erythropoietin and arginase II selective inhibitors KUD 974 and KUD 259 in experimental preeclampsia
by: Tatyana I. Lokteva, et al.
Published: (2020) -
Study of the effect of acetylsalicylic acid and a selective arginase II inhibitor KUD 975 on the correction of hemostatic disorders in experimental preeclampsia
by: Anastasia V. Gureeva, et al.
Published: (2022) -
Correction of morphofunctional disorders with asialoerythropoietin and selective inhibitor of arginase II KUD975 in cases of ischemic kidney damage in the experiment
by: Vladislav Elagin, et al.
Published: (2018)